Results 181 to 190 of about 15,411,883 (261)

Sex and Chronic Stress Alter the Distribution of Corticotropin‐Releasing Factor Receptor in Rat Hippocampus Following Oxycodone Conditioned Place Preference

open access: yesSynapse, Volume 80, Issue 5, September 2026.
Chronic stress modifies the effect of oxycodone conditioned place preference (Oxy CPP) on corticotropin releasing factor 1 (CRFR1) subcellular distributions in hippocampal subregions. These stress‐ and oxycodone‐induced changes in CRFR1 density may influence sex differences in hippocampal learning and memory processes both at baseline and following Oxy
Dana N. Silberstein   +7 more
wiley   +1 more source

Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging. [PDF]

open access: yesPLoS One
Torrent C   +8 more
europepmc   +1 more source

Deep Learning for Protein Modeling: From Single Structure to Bound Complex and Thermodynamic Ensemble, With a Focus on Architectural Design

open access: yesWIREs Computational Molecular Science, Volume 16, Issue 5, September/October 2026.
Protein deep learning is moving from single structure prediction toward bound complex modeling and conformational ensemble generation. An architectural perspective shows how symmetry, evolutionary information, generative sampling, and energetic grounding shape performance and generalization.
Daniele Angioletti   +3 more
wiley   +1 more source

Guiding the Application of Immunotherapy in Nonsmall Cell Lung Cancer: The Role of Biomarkers

open access: yesThoracic Cancer, Volume 17, Issue 18, September 2026.
The content is divided into three main parts: (1) Predictive biomarkers: this includes six detailed subcategories. (2) Prediction of immune resistance: Lists relevant cell and gene markers. (3) Prediction of immune‐related adverse reactions. ABSTRACT Although immunotherapy has completely transformed the treatment landscape of nonsmall cell lung cancer (
Yuting Sun   +8 more
wiley   +1 more source

Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study

open access: yesThoracic Cancer, Volume 17, Issue 18, September 2026.
In 11 patients with relapsed small cell lung cancer treated with tarlatamab, CRS occurred in 63.6% and was limited to cycle 1 day 1 or day 8; all events were Grade 1–2 and manageable without tocilizumab or treatment discontinuation. One patient developed Grade 3 ICANS and fully recovered, while NLR showed an exploratory association with CRS.
Juwhan Choi, Seunghun Lee, Sung Yong Lee
wiley   +1 more source

The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma. [PDF]

open access: yesPharmacol Res Perspect
Javid FA   +3 more
europepmc   +1 more source

Novel Therapeutic Insights Into Alzheimer's Disease: Glymphatic System and Meningeal Lymphatic Vessels

open access: yesAging Cell, Volume 25, Issue 9, September 2026.
The identification of the glymphatic system (GS) and meningeal lymphatic vessels (mLVs) challenges the century‐old “immune‐privileged” dogma of the central nervous system (CNS), establishing a critical mechanistic link between impaired waste clearance (Aβ/tau) and the pathogenesis of Alzheimer's disease (AD).
Bingbing Song   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy